Our Blog

Growing data points towards use of HIVEC® in high-risk and BCG-unresponsive patients following publication of HIVEC® bladder cancer RCT results

Growing data points towards use of HIVEC® in high-risk and BCG-unresponsive patients following publication of HIVEC® bladder cancer RCT results

Aug 22, 2022

Press release, 22 August 2022 Combat Medical is pleased to announce the results of the HIVEC® II...

“There’s a new vitality in bladder cancer. And it’s exciting to have come through 20 years of agony and start to see the fruits of all that labour”

“There’s a new vitality in bladder cancer. And it’s exciting to have come through 20 years of agony and start to see the fruits of all that labour”

Aug 16, 2022

The Medical Innovators Interview with Professor Michael O'Donnell | June 2022 Gem/doce vs BCG,...

“We’re trying to find our patients’ urinary microbiota and see if it affects bladder disease”

“We’re trying to find our patients’ urinary microbiota and see if it affects bladder disease”

May 17, 2022

The Medical Innovators Interview #5 Professor Roman ZachovalMay 2022 Prostate screening, bladder...

Unmet clinical need in bladder cancer treatment

Unmet clinical need in bladder cancer treatment

Apr 12, 2022

Once upon a time, some sharp-thinking medic came up with a great idea for neatly removing unwanted...

“An entirely new treatment for late-stage ovarian cancer”

“An entirely new treatment for late-stage ovarian cancer”

Apr 12, 2022

Almost £40 billion of R&D funding was announced for the UK in the Chancellor’s Spring...

Exploring the process of medical innovation

Apr 5, 2022

When you're developing new medical devices, it's not good enough simply to have a great product....

« Older Entries

Next Entries »